Advertisement Hospira recalls a lot of magnesium sulfate in 5% dextrose injection - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hospira recalls a lot of magnesium sulfate in 5% dextrose injection

Hospira has issued a voluntary recall of one lot of Magnesium Sulfate in 5% Dextrose, Inj., USP, 10mg/mL following reports of an incorrect barcode on the primary bag labeling.

According to the company, the barcode on the overwrap is correct but the primary container barcode could be mislabeled with the barcode for Heparin Sodium 2000 USP units/1000mL in 0.9% Sodium Chloride injection.

Packaged in 50/100mL container bags and sold 24 bags per carton, the lot was distributed nationwide from October 2014 to January 2015 to wholesalers, distributors and hospitals in the US.

The prescription-based product is administered intravenously to prevent and control seizures in preeclampsia and eclampsia, respectively.

So far, Hospira has not received reports of any adverse events related with this issue for this lot.

An investigation has been already launched by Hospira to find out the root cause and take corrective and preventive actions.